Evidence map›Paper›PMID 41415601›Full record

ArticlePlastic and reconstructive surgery. Global open2025

Beyond Ultra-high Frequency: Clinical Feasibility of 10-12 MHz and Portable Ultrasound in Lymphatic Imaging.

Hisako Hara, Makoto Mihara

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hisako HaraFrom the Department of Lymphatic and Reconstructive Surgery, JR Tokyo General Hospital, Tokyo, Japan.
Makoto MiharaLymphedema Clinic Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphatic ultrasound has recently emerged as a noninvasive, contrast-free modality for evaluating lymphatic vessels, particularly as a preoperative tool for lymphaticovenous anastomosis. Although high-frequency linear probes (18-20 MHz) are commonly used, their availability may be limited, and ultra-high-frequency probes (≥30 MHz) are limited by poor tissue penetration. This study investigated the feasibility of using lower frequency linear probes (10-12 MHz), including a portable 10-MHz device, to visualize lymphatic vessels in patients with extremity lymphedema. A total of 24 limbs from 13 female patients were examined. Dilated lymphatic vessels were first identified using an 18-MHz probe, then reevaluated with either a 12- or 10-MHz probe. Among 44 sites, 86.4% of lymphatic vessels detected with the 18-MHz probe were also visible with lower frequency probes. Identification was more successful in the lower extremities (89.5%) than in the upper extremities (66.7%). Visualization rates were comparable between the 12- (87.0%) and 10-MHz (85.7%) probes. These findings suggest that lower frequency probes, including portable devices, can adequately visualize lymphatic vessels in most cases. This may facilitate wider adoption of lymphatic ultrasound in general clinical settings and resource-limited environments. However, further studies are needed to evaluate their standalone diagnostic performance and ability to assess lymphatic degeneration, and their limitations in de novo identification should also be acknowledged. Addressing these issues may help optimize probe selection and further expand the clinical utility of lymphatic ultrasound.

Identifiers

PMID41415601
PMCPMC12708155

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.